Literature DB >> 2583108

The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment.

W Bode1, I Mayr, U Baumann, R Huber, S R Stone, J Hofsteenge.   

Abstract

A stoichiometric complex formed between human alpha-thrombin and D-Phe-Pro-Arg chloromethylketone was crystallized in an orthorhombic crystal form. Orientation and position of a starting model derived from homologous modelling were determined by Patterson search methods. The thrombin model was completed in a cyclic modelling-crystallographic refinement procedure to a final R-value of 0.171 for X-ray data to 1.92 A. The structure is in full agreement with published cDNA sequence data. The A-chain, ordered only in its central part, is positioned along the molecular surface opposite to the active site. The B-chain exhibits the characteristic polypeptide fold of trypsin-like proteinases. Several extended insertions form, however, large protuberances; most important for interaction with macromolecular substrates is the characteristic thrombin loop around Tyr60A-Pro60B-Pro60C-Trp60D (chymotrypsinogen numbering) and the enlarged loop around the unique Trp148. The former considerably restricts the active site cleft and seems likely to be responsible for poor binding of most natural proteinase inhibitors to thrombin. The exceptional specificity of D-Phe-Pro-Arg chloromethylketone can be explained by a hydrophobic cage formed by Ile174, Trp215, Leu99, His57, Tyr60A and Trp60D. The narrow active site cleft, with a more polar base and hydrophobic rims, extends towards the arginine-rich surface of loop Lys70-Glu80 that probably represents part of the anionic binding region for hirudin and fibrinogen.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2583108      PMCID: PMC401503          DOI: 10.1002/j.1460-2075.1989.tb08511.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  56 in total

1.  Inactivation of trypsin-like enzymes with peptides of arginine chloromethyl ketone.

Authors:  C Kettner; E Shaw
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

2.  Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin.

Authors:  S J Degen; R T MacGillivray; E W Davie
Journal:  Biochemistry       Date:  1983-04-26       Impact factor: 3.162

3.  The mechanism of the fibrinogen-thrombin reaction.

Authors:  D H Hogg; B Blombäck
Journal:  Thromb Res       Date:  1978-06       Impact factor: 3.944

4.  Inhibition of thrombin and trypsin by tripeptide aldehydes.

Authors:  S Bajusz; E Barabás; P Tolnay; E Széll; D Bagdy
Journal:  Int J Pept Protein Res       Date:  1978-10

Review 5.  Protein inhibitors of proteinases.

Authors:  M Laskowski; I Kato
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

Review 6.  Thrombin specificity.

Authors:  J W Fenton
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

7.  Refined crystal structure of gamma-chymotrypsin at 1.9 A resolution. Comparison with other pancreatic serine proteases.

Authors:  G H Cohen; E W Silverton; D R Davies
Journal:  J Mol Biol       Date:  1981-06-05       Impact factor: 5.469

8.  Refined 2 A X-ray crystal structure of porcine pancreatic kallikrein A, a specific trypsin-like serine proteinase. Crystallization, structure determination, crystallographic refinement, structure and its comparison with bovine trypsin.

Authors:  W Bode; Z Chen; K Bartels; C Kutzbach; G Schmidt-Kastner; H Bartunik
Journal:  J Mol Biol       Date:  1983-02-25       Impact factor: 5.469

9.  Computer-generated models of blood coagulation factor Xa, factor IXa, and thrombin based upon structural homology with other serine proteases.

Authors:  B Furie; D H Bing; R J Feldmann; D J Robison; J P Burnier; B C Furie
Journal:  J Biol Chem       Date:  1982-04-10       Impact factor: 5.157

10.  Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder.

Authors:  M C Owen; S O Brennan; J H Lewis; R W Carrell
Journal:  N Engl J Med       Date:  1983-09-22       Impact factor: 176.079

View more
  192 in total

1.  A model for the binding of low molecular weight inhibitors to the active site of thrombin.

Authors:  M C Allen; X L Cockcroft; M G Gruetter; J P Priestle
Journal:  J Comput Aided Mol Des       Date:  1999-11       Impact factor: 3.686

2.  Identification of exosite residues of factor Xa involved in recognition of PAR-2 on endothelial cells.

Authors:  Chandrashekhara Manithody; Likui Yang; Alireza R Rezaie
Journal:  Biochemistry       Date:  2012-03-15       Impact factor: 3.162

3.  Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa.

Authors:  Lin Chen; Chandrashekhara Manithody; Likui Yang; Alireza R Rezaie
Journal:  Protein Sci       Date:  2004-02       Impact factor: 6.725

4.  Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin.

Authors:  A B Kelly; J M Maraganore; P Bourdon; S R Hanson; L A Harker
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

5.  Hirulog-1 and -B2 thrombin specificity.

Authors:  J I Witting; P Bourdon; J M Maraganore; J W Fenton
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

6.  "Mirror image" antagonists of thrombin-induced platelet activation based on thrombin receptor structure.

Authors:  D T Hung; T K Vu; V I Wheaton; I F Charo; N A Nelken; N Esmon; C T Esmon; S R Coughlin
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

Review 7.  Characterization of a functional thrombin receptor. Issues and opportunities.

Authors:  S R Coughlin; T K Vu; D T Hung; V I Wheaton
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

8.  Characterization of a heparin-binding site on the catalytic domain of factor XIa: mechanism of heparin acceleration of factor XIa inhibition by the serpins antithrombin and C1-inhibitor.

Authors:  Likui Yang; Mao-fu Sun; David Gailani; Alireza R Rezaie
Journal:  Biochemistry       Date:  2009-02-24       Impact factor: 3.162

9.  Expression and functional characterisation of natural R147W and K150del variants of protein C in the Chinese population.

Authors:  Qiulan Ding; Likui Yang; Seyed Mahdi Hassanian; A R Rezaie
Journal:  Thromb Haemost       Date:  2013-02-07       Impact factor: 5.249

10.  Rational design of hirulog-type inhibitors of thrombin.

Authors:  U Egner; G A Hoyer; W D Schleuning
Journal:  J Comput Aided Mol Des       Date:  1994-10       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.